<DOC>
	<DOCNO>NCT02565238</DOCNO>
	<brief_summary>The objective study confirm safety efficacy BioMonitor 2 . The data collect support regulatory approval product country outside CE region .</brief_summary>
	<brief_title>BIO.MASTER.BioMonitor 2 Study</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Syncope</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<criteria>Patients without history atrial fibrillation indication BioMonitor 2 device paients plan loop record guide AFtherapy management , either current known document paroxysmal atrial fibrillation current know documented persistent atrial fibrillation indicate ablation ablate within last four week . Patient able understand nature study provide write informed consent . Patient able willing complete plan followup visit investigational site . Patient accept Home Monitoring® concept . Age ≥ 18 year . Patients implanted ICD pacemaker . Patient pregnant and/or breastfeed intend become pregnant time study exclude . Life expectancy le 6 month . Participation another interventional clinical investigation . Participation noninterventional study permit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>